Arrowhead Pharmaceuticals Corp (ARWR) to Present Positive ARO-HBV Clinical Data Demonstrating HBsAg Reductions
Tweet Send to a Friend
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) gains 30% after the company said it will present initial clinical data for ARO-HBV, the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
